Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Tresiba Market Revenue Outlook: What CAGR Is Expected Through 2030?
The expansion observed during the historical timeframe was fueled by several key factors, including the increasing worldwide occurrence of diabetes, a higher rate of type 2 diabetes diagnoses, broader adoption of insulin therapy, more widespread recognition of the advantages associated with long-acting insulin, and the accessibility of cutting-edge insulin preparations.
The forecast period’s expansion is driven by the growing uptake of customized diabetes care strategies, the heightened utilization of digital platforms for managing the condition, the broadening availability of insulin in developing regions, a stronger emphasis on enhancing patient compliance with therapy, and greater financial backing for advanced insulin innovations. Key developments shaping this period encompass the rising use of ultra-long-acting insulin treatments, a shift toward once-daily dosing schedules, increased attention to maintaining stable blood sugar levels, the spread of patient-focused diabetes management frameworks, and improved connectivity with digital glucose tracking systems.
Download A Free Sample Report For Comprehensive Market Insights:
Tresiba Market Development Factors: Which Trends Are Supporting Demand?
The growing number of diabetes cases is set to drive the expansion of the tresiba market in the coming period. Diabetes represents a long-term medical issue where the body fails to manage blood sugar (glucose) levels correctly. This rising incidence of diabetes stems from factors like inactive lifestyles, poor eating patterns, climbing obesity rates, older populations, and genetic susceptibility. Tresiba proves valuable in tackling diabetes by giving patients superior glycemic control, lowering the chance of hypoglycemia, and offering adaptable dosing schedules that boost treatment compliance and enhance overall diabetes care results. For example, in June 2023, the Institute for Health Metrics and Evaluation, a public health research organization based in the United States, reported that over half a billion individuals worldwide were living with diabetes in 2023. This figure is projected to more than double, reaching 1.3 billion people by 2050. Consequently, the increasing prevalence of diabetes is fueling growth in the tresiba market.
The climbing obesity rates are anticipated to fuel growth in the tresiba market moving ahead. Obesity is a health condition defined by an excess of body fat that can adversely affect an individual’s wellbeing. It is commonly assessed using body mass index (BMI), a calculation based on a person’s weight relative to height. The growing obesity prevalence results from changes in global food systems and dietary practices, marked by higher intake of ultra-processed foods, sedentary behaviors, and economic conditions that make unhealthy food options easier to access. Tresiba supports obese patients by offering long-acting insulin that facilitates better blood sugar control, lowers the likelihood of hypoglycemia, and aids weight management through flexible dosing possibilities. As an illustration, in May 2024, the Office for Health Improvement & Disparities, a UK government agency, stated that during 2022 to 2023, around 64.0% of adults aged 18 and older in England were considered overweight or obese. Thus, the increase in obesity is propelling the tresiba market forward.
Tresiba Market Segment Landscape: Which Areas Lead Market Development?
The tresiba market covered in this report is segmented –
1) By Indication: Diabetes Type 1, Diabetes Type 2
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Online Pharmacies
3) By End User: Adults, Geriatric Patients, Pediatric Patients
Tresiba Market Transformation Trends: Which Innovations Are Driving Change?
The primary shift observed in the Tresiba market revolves around the rise of unbranded biologics, which offer cheaper options compared to branded drugs by broadening access to insulin therapy without compromising patient safety or effectiveness, especially in price-sensitive regions. Unbranded biologics are defined as biological products that match their branded equivalents in terms of molecular structure, quality, safety, and efficacy, though they are sold without a trademarked name. As an example, in September 2022, Novo Nordisk A/S, a pharmaceutical company headquartered in Denmark, revealed the debut of its FDA-cleared unbranded biologic version of Tresiba (insulin degludec)—a long-acting basal insulin aimed at controlling elevated blood glucose in diabetic patients aged one year and older. This unbranded product is now available through prescription, with the goal of increasing affordability, particularly for those without insurance or with inadequate coverage, as part of broader initiatives to deliver more accessible insulin choices.
Tresiba Market Industry Leaders And Market Competition
Major companies operating in the tresiba market are Novo Nordisk A/S
Access The Complete Tresiba Market Report:
Tresiba Market Leading Geography: Which Region Generates The Most Revenue?
North America was the largest region in the tresiba market in 2025. The regions covered in the tresiba market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model